These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 35291561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
    Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D'Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Chui HC, Tcw J, Chen Y, Pa J, Conti PS, Law M, Toga AW, Zlokovic BV.
    Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.
    Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV.
    Nature; 2012 May 16; 485(7399):512-6. PubMed ID: 22622580
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta.
    Ding Y, Palecek SP, Shusta EV.
    Fluids Barriers CNS; 2024 Oct 11; 21(1):79. PubMed ID: 39394110
    [Abstract] [Full Text] [Related]

  • 6. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
    Kunzler J, Youmans KL, Yu C, Ladu MJ, Tai LM.
    Neurosci Lett; 2014 Feb 07; 560():131-6. PubMed ID: 24368217
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K, Saito Y, Saito H, Toyoda M, Abe R, Saito T, Saido TC, Michikawa M, Taru H, Sobu Y, Hata S, Nakaya T, Suzuki T.
    Neurobiol Aging; 2023 Mar 07; 123():63-74. PubMed ID: 36638682
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
    Tachibana M, Holm ML, Liu CC, Shinohara M, Aikawa T, Oue H, Yamazaki Y, Martens YA, Murray ME, Sullivan PM, Weyer K, Glerup S, Dickson DW, Bu G, Kanekiyo T.
    J Clin Invest; 2019 Mar 01; 129(3):1272-1277. PubMed ID: 30741718
    [Abstract] [Full Text] [Related]

  • 14. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA, Zhou B, Nabet AM, Wernig M, Südhof TC.
    J Neurosci; 2019 Sep 11; 39(37):7408-7427. PubMed ID: 31331998
    [Abstract] [Full Text] [Related]

  • 15. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes.
    Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, Victor MB, Bonner JM, Mathys H, Lin YT, Ko T, Bennett DA, Cam HP, Kellis M, Tsai LH.
    Nat Med; 2020 Jun 11; 26(6):952-963. PubMed ID: 32514169
    [Abstract] [Full Text] [Related]

  • 16. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF, Cronican AA, Saleem M, Fauq AH, Chapman R, Lefterov I, Koldamova R.
    J Neurosci; 2012 Sep 19; 32(38):13125-36. PubMed ID: 22993429
    [Abstract] [Full Text] [Related]

  • 17. Modeling Mixed Vascular and Alzheimer's Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice.
    Hayden EY, Huang JM, Charreton M, Nunez SM, Putman JN, Teter B, Lee JT, Welch A, Frautschy S, Cole G, Teng E, Hinman JD.
    Transl Stroke Res; 2020 Oct 19; 11(5):1064-1076. PubMed ID: 32086779
    [Abstract] [Full Text] [Related]

  • 18. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
    Liu DS, Pan XD, Zhang J, Shen H, Collins NC, Cole AM, Koster KP, Ben Aissa M, Dai XM, Zhou M, Tai LM, Zhu YG, LaDu M, Chen XC.
    Mol Neurodegener; 2015 Mar 05; 10():7. PubMed ID: 25871877
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
    Hartman RE, Laurer H, Longhi L, Bales KR, Paul SM, McIntosh TK, Holtzman DM.
    J Neurosci; 2002 Dec 01; 22(23):10083-7. PubMed ID: 12451108
    [Abstract] [Full Text] [Related]

  • 20. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.
    Marottoli FM, Katsumata Y, Koster KP, Thomas R, Fardo DW, Tai LM.
    ASN Neuro; 2017 Dec 01; 9(4):1759091417719201. PubMed ID: 28707482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.